Psicofarmacologia

PrefazioneLa 14esima edizione delle Linee Guida è stata scritta nel corso del verificarsi di una circostanza straordinaria: la pandemia da coronavirus. Questo fenomeno globale ha modificato radicalmente le vite e le pratiche lavorative di miliardi di persone e la maggior parte di noi, oggi, ha conosciuto, personalmente o indirettamente, la grave malattia fisica associata al COVID-19. Ad esserne particolarmente colpiti sono stati gli operatori sanitari che si trovano ad essere a contatto con quanti si sono ammalati, rischiando essi stessi di contrarre l’infezione. In un simile contesto, la stesura di un libro ha una priorità estremamente bassa, se non addirittura nulla. È tenendo conto di ciò che rivolgo il mio più vivo e sincero ringraziamento a tutti coloro che hanno contribuito alla realizzazione di questa edizione delle Linee Guida in condizioni così difficili. Naturalmente, durante la pandemia, i problemi di salute mentale non sono scomparsi e il trattamento ottimale delle malattie mentali rimane un imperativo vitale. Tale obiettivo diventa ancora più importante quando affrontiamo le conseguenze della pandemia. Questa edizione delle Linee Guida è stata accuratamente aggiornata ed include le ricerche più influenti pubblicate a partire dal 2017 e tutti i principali farmaci psicotropi che sono stati da allora introdotti. Questa edizione prevede inoltre nuove sezioni dedicate a temi quali il delirium con agitazione, l’impiego dei farmaci psicotropi nei pazienti terminali, le formulazioni dei farmaci psicotropi da somministrare per via endovenosa, la somministrazione di clozapina per via intramuscolare e la somministrazione settimanale di penfluridolo per via orale. Come le precedenti, questa 14esima edizione è stata realizzata con l’intento di avere un’utilità a livello mondiale, pur avendo una certa influenza soprattutto nel Regno Unito. Vorrei rivolgere un ringraziamento particolare a Siobhan Gee per il meticoloso lavoro compiuto sull’impiego della clozapina, a Mark Horowitz per le indicazioni basate sull’evidenza e incentrate sul paziente in relazione alla cessazione della somministrazione dei farmaci psicotropi, a Delia Bishara, la quale si è occupata praticamente da sola del capitolo dedicato agli anziani e a Ian Osborne per il contributo fornito in relazione ad una gamma eccezionalmente ampia di temi. Un riconoscimento particolare merita Emily Finch per l’organizzazione della stesura del capitolo sulle dipendenze nelle ultime dieci edizioni del le Linee Guida. Infine voglio porgere il mio ringraziamento alla mia assistente Ivana Clark,  che ha contribuito alla realizzazione di questa edizione con pazienza e incomparabile attenzione al dettaglio. David M. TaylorLondraMarzo 2021

L'opera è considerata da sempre il principale riferimento nel campo della neurofarmacologia

L'uso dei farmaci antidepressivi, soprattutto quelli di nuova generazione, è in continua crescita, sembra che almeno una perso

La psicofarmacologia del bambino e dell'adolescente è un campo in rapida espansione nel quale si utilizzano estesamente i farm

Following the success of the first two volumes in Stahl's Case Studies series, a brand new collection of clinical stories have been collated in Volume 3, derived from cases seen by medical students, residents and faculty from the University of California at Riverside (UCR) Department of Psychiatry and Neuroscience. The highly popular and unique user-friendly presentation of previous volumes has been maintained, with extensive use of icons, questions/answers, and tips. The cases address multifaceted issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way. The book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey. This is psychiatry in real life.

The Maudsley Prescribing Guidelines in Psychiatry The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe and effective prescribing of psychotropic agents. Covering both common and complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum and maximum doses, adverse effects, switching medications, prescribing for special patient groups, and more. Each clear and concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based. The fourteenth edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions, and all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand, and Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry: Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression and anxiety, borderline personality, eating disorders, and many others Provides advice on prescribing for children and adolescents, older people, pregnant women, and other special patient groups Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses, and dopamine super-sensitivity Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco, and caffeine, and treating patients with comorbid physical conditions Whether in the doctor's office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, Fourteenth Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses, and other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy, and nursing.

La psicofarmacologia ha un ruolo molto importante tra gli interventi integrati per i disturbi psichici nelle persone affette d

La Guida alla prescrizione fornisce le informazioni pratiche sull’uso dei farmaci psicotropi – quelli in grado di agire sulle funzioni psichiche dell'individuo – utili nell’attività clinica quotidiana. La trattazione di ogni farmaco è suddivisa in cinque sezioni, ciascuna contraddistinta da uno specifico colore: Informazioni terapeutiche, Effetti collaterali, Posologia e modalità d’uso, Popolazioni speciali e Arte della psicofarmacologia. Quest’ultima sezione è dedicata alle opinioni dell’Autore su questioni come i potenziali vantaggi o svantaggi del farmaco, i principali sintomi bersaglio e una serie di notazioni cliniche che hanno lo scopo di ottimizzare l’impiego del farmaco (Perle cliniche). Il volume è caratterizzato da un tipo di comunicazione verbale-iconico, in cui l’immagine e il testo si completano a vicenda, il che permette una facilità di impiego e una consultazione rapida. Prontuario indispensabile in psicofarmacologia: riassunto aggiornato e completo dei farmaci psicotropi utilizzati in pratica clinica. Un aiuto indispensabile per chiunque prescriva terapie nel campo della salute mentale, facile e schematico da consultare, è corredato di diversi indici. Rispetto alla precedente edizione comprende 11 nuovi composti e fornisce informazioni su diverse nuove formulazioni di farmaci già esistenti. Inoltre, vi sono riportate molte recenti indicazioni importanti dei farmaci già conosciuti. L’intera trattazione è stata aggiornata con le formulazioni iniettabili e transdermiche e con le ultime indicazioni e avvertenze. Adattato alla realtà italiana: nella traduzione sono stati utilizzati alcuni accorgimenti al fine di permettere al lettore di identificare ciò che è specifico nel nostro Paese; i farmaci non disponibili in Italia sono contrassegnati dalla dicitura “ND”, così come sono state controllate le indicazioni approvate nel nostro sistema sanitario (evidenziate in neretto). Unisce i dati basati sull’evidenza alle informazioni terapeutiche incentrate sulla competenza clinica: l’obiettivo dell’Autore è quello di integrare l’arte della pratica clinica con la scienza della psicofarmacologia. Complemento al volume Neuro Psicofarmacologia Essenziale dello stesso Autore (2016), uno dei testi di psicofarmacologia più venduti al mondo.

In questo libro la natura rivoluzionaria degli antipsicotici è messa in seria discussione

Learn to improve your assessment, investigation, and management of physical health conditions in people with severe mental illness The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry offers psychiatric and general practitioners an evidence-based and practical guide for the appropriate assessment, investigation, and management of common physical health conditions seen in people with severe mental illness. Written by a renowned team of respected experts in medicine, surgery, pharmacy, dietetics, physiotherapy, and psychiatry, the book bridges the gap between psychiatric and physical health services for the severely mentally ill. The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry also provides practitioners with expert guidance on making effective referrals to other medical and surgical subspecialties, telling readers what information subspecialties would expect to receive. Its use will improve the quality of clinical care received by mentally ill patients and, by promoting a holistic approach to treatment that considers both body and mind, will enhance the therapeutic relationship between patient and practitioner. The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry covers the following: Guidance on assessment and management of well over a hundred different medical and surgical presentations commonly seen in people with serious mental illness Management of physical health emergencies in a psychiatric setting Evidence-based approaches to management of physical side effects of psychiatric medications Advice on approaches to promote a healthy lifestyle in people with serious mental illness, such as smoking cessation and changes to diet and physical activity Perfect for both psychiatrists and general practitioners who wish to improve the quality of care they provide to people with serious mental illness, The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry will be of use to anyone setting out to navigate the divide between the treatment of psychiatric and physical health conditions.

A guide to treating psychosis that provides information on drug options and side-effects in order to allow for weighing treatment options knowledgably The Maudsley Guidelines on Advanced Prescribing in Psychosis offers a resource that puts the focus on the need to treat the individual needs of a patient. The authors – noted experts on the topic – offer an alternative to the one-size-fits-all treatment of psychosis and shows how to build psychiatrist and patient relationships that will lead to effective individual treatment plans. The book provides up-to-date data and information about commonly used anti-psychotic drugs and drugs used in bipolar disorder. The text weighs both the upsides and downsides of each pharmaceutical presented, and helps prescribers and patients weigh the costs and benefits of various options to reach an appropriate treatment plan. The authors highlight the treatment at a population level and the systems in which individual treatments take places. This important resource: Facilitates the tailoring of an appropriate treatment plan for clients manifesting signs of psychosis Offers a comparative strategy that helps gauge the suitability of one treatment plan over another Provides at-hand data and information about commonly used anti-psychotic drugs Includes an understanding of the origins and side-effects of each drug presented The Maudsley Guidelines on Advanced Prescribing in Psychosis offers psychiatrists and other mental health practitioners an essential guide for treating psychosis on an individualized level.

La Guida all'Uso dei Farmaci in Psichiatria riassume i principi generali di terapia delle principali sindromi psichiatriche, c

Schatzberg's Manual of Clinical Psychopharmacology is a meticulously researched, yet down-to-earth guide for practitioners prescribing psychotropic medications to individuals with psychiatric disorders or symptoms mandating treatment. The ninth edition offers up-to-date information on current drugs, interactions, side effects, and dosing guidelines, and retains the strengths and features that have made it a standard text for trainees and practicing clinicians. The authors also include a new chapter on important developments in laboratory-guided pharmacotherapy, including pharmacogenomic testing, neurocognitive testing, quantitative EEG, and neuroimaging. Although the book's primary purpose is to provide the reader-practitioner with basic and practical information regarding the many classes of psychiatric medications, the authors stress that understanding how to select and prescribe psychotropic medications does not obviate the basic need to comprehensively evaluate and understand psychiatric patients. Accordingly, the book draws on the authors' clinical experience, as well as on the scientific literature, resulting in an accessible, yet rigorous text. Features that have helped cement this book's reputation include: • Coverage is not limited to long-standing and newly approved medications, but also includes agents that are likely to receive approval from the FDA in the near future, ensuring that the reader stays up-to-date. • References are provided for key statements, and each chapter is then followed by a list of selected relevant articles and books for readers who want to go beyond the material presented, making for a leaner, more reader-friendly guide. • Dozens of summary tables with key information on classes of psychotropics function as quick-reference guides, promoting learning and serving as convenient resources for overloaded clinicians. • The appendix offers two kinds of suggested readings. The first, for clinicians, is invaluable to trainees, while the second, for patients and families, helps point clinicians to books aimed at a lay audience to supplement information provided to patients. Staying abreast of both new medications and promising treatment protocols is essential in this rapidly evolving field. Schatzberg's Manual of Clinical Psychopharmacology delivers authoritative information in a friendly, collegial style, ensuring that both students and practicing clinicians are equipped to provide a superior standard of care.

Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. For nearly 25 years, Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment has been an authoritative source of up-to-date, easy-to-find information on the full spectrum of psychiatric drug therapy. Now fully revised, the Seventh Edition of this essential guide remains the drug reference of choice for psychiatrists and other physicians, as well as psychiatric residents, medical students, clinical psychologists, psychiatric nurses, and other professionals who provide care for the mentally ill. Includes many new FDA-approved drugs, as well as updated information about drug selection and use that reflects both research data and clinical experience. Presents information in a clear, concise manner, classifying drugs according to their pharmacological activity and mechanism of action. Includes separate, updated chapters on nutritional supplements and herb preparations, drugs used in the treatment of obesity, and medication-induced movement disorders. Provides a wealth of data for each drug: chemical name; preparation and dosages; pharmacologic actions; indications for use and clinical applications; use in children, elderly persons, and pregnant and nursing women; side effects and adverse and allergic reactions; and drug-drug interactions. Reflects DSM-5 classification guidelines throughout. Enrich Your eBook Reading Experience with Enhanced Video, Audio and Interactive Capabilities! Read directly on your preferred device(s), such as computer, tablet, or smartphone Easily convert to audiobook, powering your content with natural language text-to-speech Adapt for unique reading needs, supporting learning disabilities, visual/auditory impairments, second-language or literacy challenges, and more